Skip to main content
. 2024 Aug 26;2024:1546629. doi: 10.1155/2024/1546629

Table 3.

Difference between systolic and diastolic ventricular and atrial function comparing normal with elevated NT-proBNP groups for systolic and diastolic functional parameters.

EF ≥ 50% EF <50% Atrial fibrillation
Group A Group B Group C
n 1716 72 162 12 61 11
Low NT-proBNP High NT-proBNP Low NT-proBNP High NT-proBNP Low NT-proBNP High NT-proBNP
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD

PACS (%) 20.6 ± 6.0 19.8 ± 5.9 18.3 ± 7.1 13.8 ± 5.2 18.5 ± 7.2 10.5 ± 8.4
ACS (%) 26.1 ± 12.7 22.0 ± 10.1 19.4 ± 10.4 15.2 ± 7.0 23.3 ± 14.1 16.7 ± 12.0
ATS (%) 46.7 ± 15.2 42.0 ± 13.3 37.6 ± 13.9 29.0 ± 10.9 41.7 ± 18.1 27.1 ± 17.4
Atrial SR S (1/s) 2.45 ± 0.97 2.26 ± 0.92 2.09 ± 0.89 1.41 ± 0.62 2.12 ± 0.90 1.35 ± 0.93
Atrial SR E (1/s) −2.25 ± 1.03 −1.98 ± 0.92 −1.67 ± 0.73 −1.27 ± 0.45 −1.90 ± 0.99 −1.46 ± 0.85
Atrial SR A (1/s) −2.90 ± 0.98 −2.76 ± 1.17 −2.66 ± 1.09 −1.90 ± 0.81 −2.58 ± 1.12 −1.38 ± 0.95
LASI (1/%) 0.23 ± 0.16 0.28 ± 0.17 0.34 ± 0.27 0.45 ± 0.25 0.41 ± 1.04 1.06 ± 1.73
MV E (cm/s) 67.2 ± 16.2 64.8 ± 16.5 60.8 ± 15.7 54.0 ± 14.6 67.4 ± 21.3 83.2 ± 51.4
MV A (cm/s) 64.1 ± 15.4 64.6 ± 17.3 68.2 ± 16.1 71.2 ± 12.4 66 ± 17 62 ± 26
MV E/A (1/1) 1.10 ± 0.36 1.05 ± 0.33 0.93 ± 0.33 0.76 ± 0.15 1.05 ± 0.35 1.60 ± 1.05
MV DT (ms) 190 ± 47 211 ± 50 198 ± 48 182 ± 43 182 ± 47 190 ± 62
LA volume index (ml/m2) 22.7 ± 8.4 23.6 ± 10.9 21.5 ± 8.0 23.2 ± 11.9 23 ± 11 37 ± 24
E/e´ () 9.67 ± 3.22 10.5 ± 3.98 11.0 ± 4.3 12.8 ± 4.7 10.8 ± 5.8 12.7 ± 11.0
TAPSE (cm) 2.39 ± 0.40 2.33 ± 0.42 2.25 ± 0.41 1.91 ± 0.59 2.42 ± 0.53 2.02 ± 0.50
TR PG (mmHg) 16.2 (6/20) 16.5 (12/20) 14.3 (3.8/17) 14.9 (1.7/19) 17.4 (3.1/17) 21.7 (13/24)
Velocity basal septal E (cm/s) −6.5 ± 2.1 −5.9 ± 1.8 −5.2 ± 1.8 −4.5 ± 1.6 −6.0 ± 2.1 −6.3 ± 2.5
Velocity basal lateral E (cm/s) 8.4 ± 2.7 7.7 ± 2.6 −6.5 ± 2.6 −5.2 ± 2.6 −7.6 ± 2.9 −7.9 ± 2.9
Velocity basal septal A (cm/s) −7.5 ± 1.7 −7.6 ± 1.7 −7.2 ± 1.8 −6.7 ± 2.3 −6.8 ± 2.5 −5.0 ± 2.8
Velocity basal lateral A (cm/s) −6.9 ± 2.5 −7.4 ± 2.4 −6.3 ± 3.0 −6.0 ± 3.0 −6.5 ± 2.8 −4.7 ± 3.1
LV Stoke volume (ml) 85.7 ± 22.2 82.2 ± 20.1 84.8 ± 22.0 71.6 ± 14.6 91.6 ± 24.1 88.8 ± 12.0
LV EF (%) 56.8 ± 5.5 56.3 ± 4.3 43.3 ± 5.2 39.9 ± 9.9 55 ± 7 49 ± 9
LV EDV (ml) 129 ± 32 122 ± 39.7 140 ± 40 151 ± 41 140 ± 35 152 ± 64
LV ESV (ml) 43 ± 16 40 ± 23 56 ± 27 79 ± 46 48 ± 18 64 ± 61
LV mass index (g/m2) 119 ± 36 123 ± 39 130 ± 40 120 ± 256 128 ± 40 134 ± 25
LV ES long strain (%) −20.3 ± 2.7 −19.7 ± 2.7 −17.7 ± 3.1 −15.0 ± 5.9 −19.9 ± 4.1 −18.4 ± 6.2
LV PL SR S (1/s) −1.20 ± 0.20 −1.19 ± 0.20 −1.12 ± 0.21 −0.95 ± 0.38 −1.17 ± 0.23 −1.21 ± 0.34
LV PL SR E (1/s) 1.56 ± 0.34 1.43 ± 0.35 1.29 ± 0.33 1.09 ± 0.34 1.55 ± 0.44 1.54 ± 0.60
LV PL SR A (1/s) 1.11 ± 0.27 1.16 ± 0.26 1.02 ± 0.36 1.13 ± 0.32 1.09 ± 0.29 0.86 ± 0.27

PACS: peak atrial contraction strain; ACS: atrial conduit strain; ATS: atrial total strain; SR: strain rate; S: during systole; E: during early filling phase; A: during atrial contraction; LASI: left atrial stiffness index (E/E´/LA strain); MV: mitral valve; DT: deceleration time; LA: left atrium; TAPSE: tricuspid annular plane systolic excursion; TR PG: tricuspid regurgitation peak gradient; LV: left ventricle; EF: ejection fraction; EDV: end diastolic volume; ESV: end systolic volume; ES: end systolic; PL: peak longitudinal. Pairwise comparisons with p < 0.05 for difference between groups with normal and high NT-proBNP; median (IQR).